OrbiMed launches next-gen immunotherapy startup Adicet with $51M
The company also just acquired Israel-based Applied Immune Technologies, meant to fine tune its development of monoclonal antibodies.
aya jakobovits
The company also just acquired Israel-based Applied Immune Technologies, meant to fine tune its development of monoclonal antibodies.